Lenalidomide enhances anti-myeloma cellular immunity.
Luptakova K, Rosenblatt J, Glotzbecker B, Mills H, Stroopinsky D, Kufe T, Vasir B, Arnason J, Tzachanis D, Zwicker JI, Joyce RM, Levine JD, Anderson KC, Kufe D, Avigan D.
Luptakova K, et al. Among authors: glotzbecker b.
Cancer Immunol Immunother. 2013 Jan;62(1):39-49. doi: 10.1007/s00262-012-1308-3. Epub 2012 Jun 24.
Cancer Immunol Immunother. 2013.
PMID: 22733396
Free PMC article.